Stryker
Stryker

Stryker to sell U.S. spinal implants business

Stryker has agreed to sell its US spine implant business to Viscogliosi Brothers with plans to create a newly formed company called VB Spine, LLC.  The deal also includes a binding offer for Stryker’s French spine business, and the company said it plans to sell its spine implants businesses in other international markets.

Continue reading →

Viewpoints on MedTech
Viewpoints on MedTech

Leveraging New U.S. Healthcare Policies: How can MedTech startups find the right investors?

By Daniele Viappiani

With a new executive order to leave the World Health Organization, the Make America Healthy Again (MAHA) movement is driving new policy and promises for faster time to market for product innovation. MedTech start-ups are keen to capitalize on the opportunity, yet funding to push product through early product phases – concept and design through clinical studies and post-market surveillance – can be complex. Daniele Viappiani of GC1 Ventures offers strategies for MedTech start-ups to find the right investors.

Continue reading →

How will deregulation in the US affect the international medical device market?

By Matt Burton

The United States is currently under the spotlight as Donald Trump’s recent appointment and consequent nomination of Robert F. Kennedy Jr as Department of Health and Human Services secretary are likely to bring a series of crucial changes that will affect the medical device market globally. Manufacturers everywhere are addressing their attention to the US market and waiting for new decisions to be made. In particular, deregulation is on the cards for the sector and the biggest concern is the restructure of the Food and Drug Administration (FDA), as a reduction in regulatory red-tape, though favoring increased competition, could also dangerously shrink examination processes.

Continue reading →